Skip to content

Zai Lab

US · ZLAB #2554 by market cap Listed 2017
21.03 -0.89 -4.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Zai Lab

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Founded
2014
CEO
Dr. Samantha Du, PhD
Employees
1,784
Headquarters
Shanghai, Shanghai, China
Fiscal year end
12-31
Website
zailaboratory.com

Company profile

Exchange
US
Symbol
ZLAB
Market-cap rank
#2554
Listing date
2017-09-20
Market cap
2.36B
Float cap
1.96B
Shares out
112.44M
Float shares
93.42M

Sectors & themes

Biotechnology China Concept Stocks HK ADR Fractional Shares JP Chinese Concept

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Zai Lab discussion 0 comments

Add a comment